Current News

Questioning $1 Million Fee in a Needle Deal

Investrend Update: RVP Well Capitalized for Future Growth

Retractable Technologies Bolsters Financial Position Through Major Balance Sheet Restructuring

Investrend Update Available for RVP

Retractable Technologies Signs Agreements to Market VanishPoint® Safety Needle Devices to the Benelux Countries, Denmark and Sweden

Retractable Technologies Signs Agreement to Produce VanishPoint® Safety Syringes in China for Global Market

New York Times: A Mission to Save Money, a Record of Otherwise

Letter to Shareholders Dated May 31,2002

Centers for Disease Control Selects VanishPoint (R) Safety Needle Devices for Anthrax Vaccine Study

Investrend Research Update on Retractable Technologies: Q1, 2002 Results In-Line With Expectations

17 18 19 20 21 22 23 24

<< < > >>

Retractable Technologies Inc. - Privacy